Skip to content

Instant Message-delivered Brief Internet-based Cognitive Behavioural Therapy (iCBT) for Post-stroke Depression

Instant Message-delivered Brief Internet-based Cognitive Behavioural Therapy (iCBT) for Post-stroke Depression: a Mixed Method Study

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05892965
Enrollment
160
Registered
2023-06-07
Start date
2023-05-01
Completion date
2025-06-30
Last updated
2024-07-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depressive Symptoms, Mobile Phone Use, Stroke

Brief summary

Around one third of stroke survivors develop depression at any point of time following the stroke event. Post-stroke depression (PSD) is associated with negative care outcomes including poorer function, longer hospital stays, increased outpatient and inpatient clinic use, and higher mortality rate. In Hong Kong (HK), the prevalence of PSD within the hospital setting was 36%, and up to 68% in the community setting. However, PSD is seldom addressed in either settings in HK and elsewhere. Meta-analyses reported the effectiveness of Internet-based cognitive behavioural therapy (iCBT), particularly when guided by therapists (d = 0.63). Personalised and synchronous instant message-based intervention guided by therapists is an emerging form of psychological intervention. While such intervention showed medium to large effect (Hedges' g = 0.73) on negative psychological distress episodes including depression, no study has investigated its effect on PSD. The proposed study aims to 1) investigate the effect of therapist-guided brief iCBT delivery through instant messaging applications (e.g. WhatsApp and WeChat) to provide personalised and synchronous PSD support and 2) understand the experience of and compliance with the intervention. 160 community-dwelling stroke survivors with Patient Health Questionnaire-9 (PHQ-9) scores ranging from 5 to 19 indicating mild to moderate depressive symptoms will be recruited and then individually randomised into the Intervention group (n=80) or Control group (n=80). Intervention group will receive 1) instant message-delivered brief iCBT for 3 months at participants' chosen times and frequencies, and 2) therapist-led text or voice message-based PSD support to enhance the effects of iCBT through real-time counselling and practical advice. Control group will only receive messages on general mental health information and reminders to participate in follow-up surveys. The primary outcome is PHQ-9 score at 6 months. Secondary outcomes will include anxiety (GAD-7), perceived stress (PSS-4), loneliness (ULS-8), and quality of life (EQ-5D-5L) at 6 months. The study will strictly follow the CONSORT-EHEALTH checklist. Post-trial qualitative study will be conducted to understand the participants' experience of and compliance with the intervention (n≈20) respectively. This study will provide the first and practical evidence on the effectiveness of instant message-delivered brief iCBT intervention in addressing PSD in HK and beyond.

Interventions

Consists of brief iCBT for psychological support (mandatory), stroke care education (optional), and nurse-led real-time chat-based support messages, delivered according to participants' preferences.

Sponsors

The University of Hong Kong
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Diagnosis of stroke (ICD-10 codes: I60-I69); * Aged ≥18; * Able to read and communicate in Chinese (Cantonese or Putonghua); * Able to use the text or voice messaging function on smartphone; * MoCA 5-minute Protocol (cognitive screen) ≥14; * Community-dwelling * Less than 1 year after stroke event; * PHQ-9 (depressive symptom) score ranging from 5 to 19 (note. mild: 5-9, moderate: 10-14, moderately severe: 15-19 and severe: 20-27)

Exclusion criteria

* Diagnosis of psychiatric disease before stroke event or currently taking psychotropic drug including antidepressants * PHQ-9 ≥ 20 (i.e., severe depressive symptom) * Currently participating in any type of psychological intervention

Design outcomes

Primary

MeasureTime frameDescription
Depressive symptoms (Patient Health Questionnaire-9 [PHQ-9])24-weekA 9-item scale with score ranging from 0 to 27, higher scores indicate higher severity of depressive symptom

Secondary

MeasureTime frameDescription
Anxiety symptoms (Generalized Anxiety Disorder-7 [GAD-7])24-weekA 7-item scale with score ranging from 0 to 21, higher scores indicate higher severity of anxiety symptoms
Stress level (Perceived Stress Scale [PSS-4])24-weekA 4-item scale with score ranging from 0 to 16, higher scores indicate higher severity of stress
Quality of life (EuroQol 5-dimension 5-level questionnaire [EQ-5D-5L])24-weekA 5-item scale with predicted values ranging from -.864 to 1, higher values indicate higher health-related quality of life
Loneliness level (UCLA Loneliness Scale [ULS-8])24-weekThe total score (8 items) ranges from 8 to 32 points, with higher scores suggesting a higher degree of loneliness

Countries

Hong Kong

Contacts

Primary ContactJung Jae LEE
leejay@hku.hk+85239176971

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026